A Randomized, Parallel Group, Placebo-controlled, Multi-dose, Study Comparing the Generic Budesonide/Formoterol 4.5 mcg to Symbicort 80/4.5 in Adult Asthmatic Patients
Phase of Trial: Phase III
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Actavis
- 25 Sep 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2018.
- 25 Sep 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2016.
- 25 Sep 2017 Status changed from not yet recruiting to recruiting.